Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Neurophage Pharmaceuticals

Neurophage Pharmaceuticals

A company developing fusion-protein drug therapies to treat chronic neurodegenerative diseases, amyloidoses, Alzheimer’s and Parkinson’s diseases

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/neurophage...maceuticals
Legal Name
NeuroPhage Pharmaceuticals, Inc.
Company Operating Status
Closed
Country
United States
United States
Founded Date
January 1, 2006
Full Address
85 Bolton St, Cambridge, MA 02140, US
Industry
Consumer biotechnology
Consumer biotechnology
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Neuroscience
Neuroscience
Investors
Shire (pharmaceutical company)
Shire (pharmaceutical company)
Merieux Equity Partners
Merieux Equity Partners
Latest Funding Round Date
March 2014
Latest Funding Type
Series D
Series D
LinkedIn URL
@groups/NeuroPhage-Pharmaceuticals-5071175/about
Location
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
17,000,000
Official Website
neurophage.com
Wellfound ID
neurophage-pharmaceuticals

Find more companies like Neurophage Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.